Results 131 to 140 of about 44,653 (211)

Inhibition of primary ciliogenesis enhances efficacy of EGFR‑TKIs against non‑small cell lung cancer cells. [PDF]

Oncol Rep
Jin L, Wei L, Hua J, Zhang R, Chen J, He J, Yang Y.   +6 more
europepmc   +1 more source

Ribonucleotide reductase M1 regulates the cell cycle via minichromosome maintenance proteins. [PDF]

Genes Dis
Malysa A, Kreahling JM, Freeman SN, Bao B, Zhao J, Zhang X, Ratnam M, Bepler G.   +7 more
europepmc   +1 more source

1-(4-Bromo-phen-yl)-4,5-diphenyl-2-(1<i>H</i>-pyrrol-2-yl)-1<i>H</i>-imidazole. [PDF]

IUCrdata
Nagaraj S, Loganathan N.
europepmc   +1 more source

Tualang honey inhibited H23 human lung adenocarcinoma cell growth by modulating the expression of functional apoptotic proteins

Frontiers in Pharmacology, 2019
Nazirah Amran, Puteri Shafinaz Abdul-Rahman, Hwee-Ming Cheng   +2 more
openaire   +1 more source

1-(4-Methyl-benzene-sulfon-yl)-1-phenyl-1<i>H</i>,2<i>H</i>-cyclo-buta[<i>c</i>]quinoline. [PDF]

IUCrdata
Schollmeyer D, Dassonneville B, Detert H.   +2 more
europepmc   +1 more source

Molecular Basis of Calcium-Induced Acidic Shift in Antimicrobial Zinc Sequestration by S100A12. [PDF]

J Phys Chem B
Kothalawala M, Shirazi S, Wang Q, Collado A, Bongiorno A, Gupta R.   +5 more
europepmc   +1 more source

On the crystal structure of tri-benzyl-tin(IV) iodide, Bz₃SnI: a correction. [PDF]

IUCrdata
Reuter NA, Reuter H.
europepmc   +1 more source

Novel Evolutionarily Conserved Oncogene COA4 is Driven by KRAS Mutant and Promotes Cancer Metastasis Through Dual Mitochondrial Metabolism-Dependent and -Independent Mechanisms. [PDF]

Adv Sci (Weinh)
Ji X, Zhang W, Xue F, Zeng J, Zhao Q, Sun X, Sun J, Zhou H, Xu Q, Ma G, Sun S, Wang Y, Mu Q, Liu Y, Wan Q.   +14 more
europepmc   +1 more source

Biotransformation of Maclekarpine E in Rats: CYP2C19-Mediated Metabolism, Fecal Enrichment, and Network Pharmacology-Based Anti-Ulcerative Colitis Prediction. [PDF]

Curr Issues Mol Biol
Yang Y, Wang L, Xue J, Dong Z, Cheng P.
europepmc   +1 more source

Integration of a novel anti-PD-1 antibody with chimeric antigen receptor-T engineered to express interleukin-7 enhances targeting efficacy against lung cancer. [PDF]

Life Med
Cheng C, Zhang L, Cao J, Li X, Wen Y, Liu K, Zhao T.   +6 more
europepmc   +1 more source